Today’s news
Some Patients Maintain Weight Loss With Less Frequent GLP-1 Injections
A small study finds that patients can keep weight off while taking popular weight loss drugs less often.

Hims & Hers Abandons Cheaper Wegovy Knockoff After FDA Warning
Telehealth company drops plan to offer compounded version of weight-loss drug following regulatory threats.
Wellgistics Launches Forzet(TM) to Address Muscle Loss from GLP-1 Drugs
New medical food targets $70B GLP-1 agonist market to help patients maintain muscle while on weight loss therapies.
Recent news
Mar. 9, 2026
TrimRx Telehealth Weight Loss Platform Examined in 2026 Consumer Research Report
Report Looks at GLP-1 Medication Access, Pricing Transparency and Safety Considerations
Mar. 9, 2026
90 Day Fiance's Kim Menzies Shows Off 70-Pound Weight Loss
The reality star is celebrating her health and fitness journey after shedding the pounds with help from a GLP-1 medication.
Mar. 8, 2026
Mindy Kaling Faces Speculation Over Weight Loss Medication
The actress's changing appearance sparks debate around GLP-1 drugs and the 'Ozempic face' phenomenon.
Mar. 5, 2026
Man Warns of 'Horrible' Side Effects from Weight Loss Drug Mounjaro
Antony Hawman's journey highlights both the transformative power and significant challenges of GLP-1 receptor medications.
Mar. 5, 2026
Obesity Groups Issue New Pharmacologic Treatment Guidance
The Obesity Society, Obesity Medicine Association, and Obesity Action Coalition provide recommendations on medications for obesity management.
Mar. 5, 2026
Bariatric Surgery Rates Fall as GLP-1s Gain Popularity
Prescriptions for semaglutide and tirzepatide increased dramatically, while metabolic and bariatric surgery rates declined.
Mar. 5, 2026
Patients Quickly Regain Weight After Stopping Weight Loss Drugs
Researchers find people regain 60% of lost weight within a year of discontinuing medications like Ozempic and Wegovy.
Mar. 5, 2026
Weight Loss Injections Can Lead to Substantial Regain After Stopping Treatment
New study finds patients may regain two-thirds of lost weight within a year of discontinuing GLP-1 medications like Mounjaro and Wegovy
Mar. 5, 2026
Omada Health Announces GLP-1 Flex Care for Employers
New program pairs virtual clinical oversight, prescribing, and lifestyle coaching with employee-paid GLP-1 medications
Mar. 5, 2026
Using GLP-1s for Weight Loss and Maintenance After Bariatric Surgery
Emerging evidence positions GLP-1s as safe and effective therapeutic options to complement surgical outcomes and improve long-term weight management.
Mar. 5, 2026
Patients Quickly Regain Weight After Stopping Weight Loss Drugs
Study finds individuals regain 60% of weight lost within a year of discontinuing medications like Ozempic and Wegovy.
Mar. 5, 2026
Oxford Study Warns of Rapid Weight Regain After Stopping Weight Loss Medications
Discontinuing drug treatments leads to faster weight rebound than ending behavioral programs, reversing cardiovascular benefits.
Mar. 4, 2026
FDA Warns Savannah Chrisley Over Misleading Claims on Weight Loss Medicine Website
Reality star's GoodGirlRX site cited for unapproved drug product claims
Mar. 3, 2026
Tess Holliday Denied Life Insurance Due to Weight
The plus-size model says she was rejected for coverage despite being healthy and active.
Mar. 3, 2026
MetaVia Highlights Early Obesity Drug Data, Teases Liver Disease Candidate
Biotech firm touts weight loss, tolerability, and potential for competitive edge with pipeline assets.
Mar. 3, 2026
Stroke Support Group Offered at RWJUH Hamilton
The free support group is open to all stroke survivors and caregivers.
Mar. 2, 2026
CitrusBurn Strategy Examined: Is the Pink Gelatin Recipe the Real Secret to Weight Loss?
Citrus Burn Facts!
Mar. 2, 2026
CitrusBurn Strategy Examined: Is the Pink Gelatin Recipe the Real Secret to Weight Loss?
Citrus Burn Facts!
Mar. 2, 2026
Uintah County, Utah Has Highest Obesity Rate in the State
Economic factors and lack of physical activity contribute to the county's high obesity levels.
Feb. 28, 2026
BreezeMeds Offers Compounded GLP-1 Weight Loss Medications
Telehealth Platform Provides Semaglutide and Tirzepatide Options, but Regulatory Landscape Evolving